UPDATE: Needham & Company Upgrades STERIS (STE) to Buy, 'Cantel Deal Provides a Source of Upside'

May 26, 2021 5:21 AM EDT Send to a Friend
(Updated - May 26, 2021 5:21 AM EDT)

Needham & Company analyst Mike Matson upgraded STERIS (NYSE: STE) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login